VCAM-1 targeted alpha-particle therapy for early brain metastases. (2020)
Attributed to:
OxCD3: Oxford Centre for Drug Delivery Devices
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/neuonc/noz169
PubMed Identifier: 31538194
Publication URI: http://europepmc.org/abstract/MED/31538194
Type: Journal Article/Review
Volume: 22
Parent Publication: Neuro-oncology
Issue: 3
ISSN: 1522-8517